Editas Medicine, Inc.
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING USHER SYNDROME AND RETINITIS PIGMENTOSA
Last updated:
Abstract:
CRISPR/Cas-related compositions and methods for treatment of Usher Syndrome and/or Retinitis Pigmentosa are disclosed herein.
Status:
Application
Type:
Utility
Filling date:
7 Jun 2021
Issue date:
5 May 2022